SCHEMBL19663012

SCHEMBL19663012

Cc1cccc2c1CC(=O)N(C1CCCC1)C2

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CREBBP Q92793 3/20 0.43
PARP1 P09874 2/20 0.42
POLB P06746 2/20 0.42
HTT P42858 1/20 0.42
ESR2 Q92731 1/20 0.42
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
MAPT P10636 1/20 0.36
C5AR1 P21730 2/20 0.36
OPRM1 P35372 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19660465 0.99 MEN1 (0.48) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL19643632 0.82 MAPT (0.46) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL19662990 0.82 POLB (0.42) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL21237182 0.82 CREBBP (0.41) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL24367777 0.82 CREBBP (0.43) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL21237206 0.81 CREBBP (0.42) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL21237209 0.79 CREBBP (0.41) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL24368127 0.77 CREBBP (0.40) MEN1KMT2ACREBBPPARP1POLB
SCHEMBL23004922 0.76 OPRM1 (0.49) MEN1KMT2APARP1POLBHTT
SCHEMBL30278373 0.76 OPRM1 (0.49) MEN1KMT2APARP1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed